Metabolic profiling in human fibroblasts enables subtype clustering in glycogen storage disease
Abstract: Glycogen storage disease subtypes I and III (GSD I and GSD III) are monogenic inherited disorders of metabolism that disrupt glycogen metabolism. Unavailability of glucose in GSD I and induction of gluconeogenesis in GSD III modify energy sources and possibly, mitochondrial function. Abnormal mitochondrial structure and function were described in mice with GSD Ia, yet significantly less research is available in human cells and ketotic forms of the disease. We hypothesized that impaired glycogen storage results in distinct metabolic phenotypes in the extra- and intracellular compartments that may contribute to pathogenesis. Herein, we examined mitochondrial organization in live cells by spinning-disk confocal microscopy and profiled extra- and intracellular metabolites by targeted LC-MS/MS in cultured fibroblasts from healthy controls and from patients with GSD Ia, GSD Ib, and GSD III. Results from live imaging revealed that mitochondrial content and network morphology of GSD cells are comparable to that of healthy controls. Likewise, healthy controls and GSD cells exhibited comparable basal oxygen consumption rates. Targeted metabolomics followed by principal component analysis (PCA) and hierarchical clustering (HC) uncovered metabolically distinct poises of healthy controls and GSD subtypes. Assessment of individual metabolites recapitulated dysfunctional energy production (glycolysis, Krebs cycle, succinate), reduced creatinine export in GSD Ia and GSD III, and reduced antioxidant defense of the cysteine and glutathione systems. Our study serves as proof-of-concept that extra- and intracellular metabolite profiles distinguish glycogen storage disease subtypes from healthy controls. We posit that metabolite profiles provide hints to disease mechanisms as well as to nutritional and pharmacological elements that may optimize current treatment strategies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Frontiers in endocrinology. - 11 (2020) , 579981, ISSN: 1664-2392
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2020
- Creator
-
Hannibal, Luciana
Theimer, Jule
Wingert, Victoria
Klotz, Katharina
Bierschenk, Iris
Nitschke, Roland
Spiekerkötter, Ute
Grünert, Sarah
- DOI
-
10.3389/fendo.2020.579981
- URN
-
urn:nbn:de:bsz:25-freidok-1700846
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hannibal, Luciana
- Theimer, Jule
- Wingert, Victoria
- Klotz, Katharina
- Bierschenk, Iris
- Nitschke, Roland
- Spiekerkötter, Ute
- Grünert, Sarah
- Universität
Time of origin
- 2020
Other Objects (12)
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease
Proteomic profiling of fibroblasts isolated from chronic wounds identifies disease-relevant signaling pathways
Mutual information based clustering of market basket data for profiling users
Ex vivo immune profiling in patient blood enables quantification of innate immune effector functions
Deep learning enables accurate clustering and batch effect removal in single-cell RNA-seq analysis
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Subtype satisfiability and entailment
Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls
Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
Clustering (20.01.2011)
Relational clustering
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease
Proteomic profiling of fibroblasts isolated from chronic wounds identifies disease-relevant signaling pathways
Mutual information based clustering of market basket data for profiling users
Ex vivo immune profiling in patient blood enables quantification of innate immune effector functions
Deep learning enables accurate clustering and batch effect removal in single-cell RNA-seq analysis
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Subtype satisfiability and entailment
Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls
Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
Clustering (20.01.2011)
Relational clustering
The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease
Proteomic profiling of fibroblasts isolated from chronic wounds identifies disease-relevant signaling pathways
Mutual information based clustering of market basket data for profiling users
Ex vivo immune profiling in patient blood enables quantification of innate immune effector functions
Deep learning enables accurate clustering and batch effect removal in single-cell RNA-seq analysis
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Subtype satisfiability and entailment
Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls
Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
Clustering (20.01.2011)